Core Insights - Cannabis stocks experienced a significant surge following President Trump's endorsement of CBD's health benefits for seniors, suggesting potential Medicare coverage and a transformative impact on senior healthcare [1][2]. Industry Overview - The market interpreted Trump's video as a tacit approval of CBD and possibly cannabis, with bipartisan support for federal-level cannabis legalization, indicating a strategic move for the president ahead of the midterm elections [2]. Company Analysis: WM Technology (MAPS) - WM Technology operates Weedmaps, a consumer platform for cannabis products, and Weedmaps for Business, a B2B software solution, generating revenue primarily from monthly subscriptions [5][6]. - MAPS stock rose approximately 17% post-video release but faced resistance at $1.35, with a potential retest at $1.25 expected [6]. - The company's revenue peaked at $215.5 million in 2022 but has since declined to $184.5 million, with profits projected to be lower in 2024 compared to 2020 [7]. - Despite the decline, WM Technology maintains a rising net cash balance and profitability, distinguishing it from other cannabis stocks that are cash-burning [7]. - Only one analyst covers MAPS stock, with a price target exceeding twice the current price [8].

Industry Overview - The cannabis industry is experiencing a positive shift following President Trump's endorsement of cannabidiol (CBD) for senior healthcare, leading to a rally in cannabis shares [1][2] - The U.S.-listed shares of Canadian cannabis companies are seeing significant gains, indicating a strong market reaction [1] Political Influence - Trump's statement on CBD as a potential alternative to traditional prescription drugs may provide momentum for the cannabis industry, which has faced strict regulations [2][3] - The possibility of reclassifying marijuana under federal law could alleviate operational and tax challenges for cannabis businesses, although it would not equate to full legalization [2][3] Market Performance - Analysts highlight that political backing, even if symbolic, is crucial for an industry struggling with regulatory hurdles [3] - The global cannabis market is projected to reach a value of $444.34 billion by 2030, showcasing its high growth potential despite volatility [4] Stock Performance - Notable stock performance includes: - Tilray Brands (TLRY) up 41.3% - Aurora Cannabis (ACB) up 23.6% - Canopy Growth (CGC) up 15.7% - Green Thumb Industries (GTBIF) up 15.7% - Curaleaf Holdings (CURLF) up 20% - Trulieve Cannabis (TCNNF) up 12.7% [5]

Core Insights - The U.S. cannabis industry is experiencing renewed momentum, with ancillary stocks gaining investor interest due to potential federal reforms and market expansion [1][3][14] - The legal cannabis market generated over $30 billion in sales last year and is projected to exceed $50 billion by 2030, highlighting significant growth potential [1] Ancillary Companies Overview - Ancillary companies provide essential tools, marketplaces, and supplies for the cannabis industry, facing fewer regulatory hurdles compared to traditional operators [1][3] - Key ancillary stocks to watch include Leafly Holdings (LFLY), WM Technology (MAPS), and GrowGeneration (GRWG), each serving different roles within the cannabis ecosystem [3][6][13] Leafly Holdings (LFLY) - Leafly is a prominent cannabis discovery and marketplace platform, connecting consumers with over 4,600 dispensaries and delivery services across legalized states [4][5] - The company is working towards profitability, with annual revenue in the mid-thirty-million-dollar range and high gross margins approaching 90% [5] - Leafly faces challenges with consistent net losses and must improve revenue per dispensary while managing cash flow [7][14] WM Technology / Weedmaps (MAPS) - WM Technology operates the Weedmaps platform, connecting over 5,200 dispensaries with consumers and providing software solutions for operational efficiency [7][9] - The company has shown signs of stabilization, with quarterly revenue around the mid-forty-million-dollar mark and a recent small net profit indicating a shift towards sustainable growth [9] - Investors should monitor WM Technology's ability to increase upselling of software tools to enhance profitability [9][14] GrowGeneration (GRWG) - GrowGeneration is a leading hydroponics and cultivation supply retailer, operating over 20 retail and distribution centers nationwide [10][12] - The company has annual revenue exceeding $160 million but faces ongoing net losses due to high operating expenses [12] - GrowGeneration is expanding into international markets, which could create new revenue streams but also requires careful expense management [12][14] Investment Considerations - As the cannabis industry matures, monitoring revenue trends, margin improvements, and balance sheet strength will be crucial for investors [14] - The ongoing discussions around federal reform and state market expansions present opportunities for ancillary players to capture growth if they execute effectively [14]

Industry Overview - The U.S. cannabis industry is projected to exceed 40 billion dollars in annual sales by 2025, driven by increasing state approvals for medical and recreational use and discussions on federal legalization [1][11] - Ancillary companies, which provide essential tools to cultivators and dispensaries without directly handling cannabis, are positioned favorably due to lower regulatory risks [1] Company Summaries GrowGeneration (GRWG) - GrowGeneration operates a significant hydroponic and organic gardening supply chain in the U.S., with a strong presence in California and operations in Colorado, Oregon, and Florida [3] - In Q2 2025, GrowGeneration reported net sales of approximately 41 million dollars, showing sequential improvement but a decline from the previous year [3] - Proprietary brands contributed over 30% to cultivation and gardening revenue, with gross profit margins exceeding 28% [3] - The company ended the quarter with nearly 50 million dollars in cash and marketable securities and has no debt, indicating a strong financial position [3] Hydrofarm Holdings Group (HYFM) - Hydrofarm is a leading distributor and manufacturer of hydroponic equipment, focusing on commercial cannabis cultivators in the U.S. and Canada [5] - For the full year 2024, Hydrofarm reported revenue of just over 190 million dollars, a decline of more than 15% year-over-year, with net income negative by over 66 million dollars [7] - The company is working on reducing excess inventory and streamlining operations to control costs, with a focus on improving gross margins [7] Scotts Miracle-Gro (SMG) - Scotts Miracle-Gro is a well-known name in consumer gardening, with its Hawthorne Gardening division supplying hydroponic equipment to cannabis cultivators [8] - In Q3 2025, Scotts reported total revenue of about 1.19 billion dollars, with Hawthorne Gardening's revenue declining by over 50% to around 33 million dollars [10] - Despite the decline in the Hawthorne division, net income rose to nearly 150 million dollars, supported by strength in the broader consumer business [10] Investment Insights - The three companies exemplify the diversity within the ancillary cannabis sector, with GrowGeneration focusing on brand value and retail scale, Hydrofarm addressing revenue challenges through cost discipline, and Scotts leveraging its consumer business stability [11] - As the cannabis industry continues to grow, these ancillary providers are essential to cultivation and supply chains, presenting unique advantages and risks for investors [11]

Financial Data and Key Metrics Changes - Revenue for Q3 reached an all-time high of $149.7 million, up 14% year-over-year and 9% sequentially [21] - Adjusted EBITDA was a record $10.6 million, up 11% year-over-year and 32% sequentially [23] - Net income turned positive at $832,000, a significant turnaround from a $2.8 million net loss in Q2 [8] - Free cash flow of $7.7 million grew 148% year-over-year, marking the second highest level since disclosure began [25] Business Line Data and Key Metrics Changes - Bricks-and-mortar revenue was a record, up 18% year-over-year, with same-store sales growth accelerating to 7.4% [6][21] - Bricks-and-mortar adjusted EBITDA reached an all-time high of $12.7 million, up 42% year-over-year [7][23] - E-commerce business continues to underperform, with less than 3% of consolidated revenues, prompting management to consider strategic changes [24][46] Market Data and Key Metrics Changes - Canna Cabana's market share across five operating provinces reached 12%, the highest since legalization [6] - In Germany, the company started with a 16% market share, leveraging its position in the two largest federally legal cannabis markets [12][18] Company Strategy and Development Direction - The company aims to expand its footprint in Germany through the acquisition of Remexian, which adds significant revenue and EBITDA to its operations [9][10] - High Tide plans to leverage relationships with licensed producers to enhance its supply chain and market presence in Germany and other European markets [14][66] - The company is focused on organic growth, targeting 20-30 new store openings in Canada while also considering potential acquisitions [38][39] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the continued strength of the bricks-and-mortar business, with no signs of slowing down in same-store sales [6][30] - The company is optimistic about the integration of Remexian and the potential for growth in the German market, despite temporary supply chain issues from Portugal [40][62] - Management highlighted the importance of maintaining a strong balance sheet while pursuing growth opportunities [17][19] Other Important Information - The company closed a $30 million junior subordinated loan with Kronos, which is seen as a validation of its strategy [17] - Management emphasized the importance of maintaining operational efficiency, with salaries and wages representing 12.2% of revenue, the lowest in seven quarters [23] Q&A Session Summary Question: On same-store sales growth and market share gains - Management indicated that the strong same-store sales growth is primarily due to having the best retail model in the country, not just competitor closures [29][30] Question: Capital allocation philosophy post-Remexian transaction - Management stated that significant working capital is required for Remexian's growth, and they plan to use raised funds for this purpose while continuing organic growth in Canada [36][38] Question: Confidence in e-commerce turnaround - Management acknowledged the underperformance of the e-commerce segment but expressed optimism about new initiatives and partnerships to drive sales [45][46] Question: Margins in bricks-and-mortar segment - Management noted that gross margins have expanded due to various factors, including white label sales and price stabilization, and they expect to maintain margins despite new store openings [49][52] Question: Performance of newer stores - Management reported that newer stores are ramping up sales faster than expected, benefiting from brand recognition and high-quality locations [58][59] Question: Opportunities across Europe - Management confirmed ongoing monitoring of other European markets for potential expansion, while focusing on successful integration with Remexian [61][62] Question: Exclusivity agreements with licensed producers - Management indicated that exclusivity agreements were expected and do not come with lower margins, as they leverage their buying power to secure favorable terms [66]

Industry Overview - The Canadian cannabis sector is crucial for investors looking to tap into the expanding U.S. marijuana market, which generated over $33 billion in sales in 2024 and is projected to exceed $50 billion by 2030 due to increasing state-level legalization and consumer demand [1][3] - Recent discussions around federal reform and rescheduling cannabis could benefit Canadian companies with U.S. partnerships or expansion plans, making them attractive to investors [1][3] Company Highlights - **Tilray Brands, Inc. (TLRY)**: - Operates in cultivation, processing, and distribution across Canada, Europe, and the U.S., focusing on hemp-derived beverages and wellness products, reaching about 1,000 retail stores [5][7] - Reported annual revenue of approximately $821 million with a gross profit of around $240 million, but net income remains negative with losses exceeding $2 billion [7] - **Canopy Growth Corporation (CGC)**: - One of the largest cannabis companies in Canada, with a strong presence in the U.S. through brands and subsidiaries rather than direct dispensary ownership [8][10] - Achieved year-over-year revenue growth of about 9%, but gross margin fell to 25% from 35% a year earlier, indicating financial strain [10] - **Village Farms International, Inc. (VFF)**: - Transitioned from agricultural production to cannabis, operating one of the largest cannabis greenhouse facilities in Canada with over 2.2 million square feet [12][14] - Reported annual revenue of about $336 million, a 17% increase from the previous year, but posted a net loss of approximately $36 million [14] Strategic Focus - Tilray is diversifying through beverages and wellness products, while Canopy is focusing on cost-cutting and U.S. brand partnerships [15] - Village Farms emphasizes efficiency and international expansion, positioning itself as one of the lowest-cost producers in Canada [14][15] Market Outlook - The Canadian cannabis sector faces challenges from oversupply and regulatory uncertainty, but leading companies are adapting their strategies to remain competitive [15][16] - September 2025 is seen as a critical period for the sector, with investors closely monitoring earnings, cost controls, and expansion efforts [16]

Industry Overview - The U.S. cannabis industry is experiencing significant growth, with legal sales surpassing $33 billion in 2024 and projected revenues of $50 billion by 2030 [1][3] - Expansion into new adult-use markets and growth in medical programs are creating new opportunities [1][3] - Federal rescheduling and potential banking reforms are increasing optimism in the sector [1][2] Key Companies - Trulieve Cannabis Corp. operates 231 retail dispensaries and has a strong presence in Florida, with a cultivation and processing footprint of over four million square feet [4][7] - Curaleaf Holdings, Inc. operates in 19 states with 154 retail dispensaries and has recently consolidated its international business, enhancing its global position [8][10] - Green Thumb Industries, Inc. operates over 101 retail locations and 20 manufacturing facilities, focusing on both adult-use and medical markets [12][14] Financial Performance - Trulieve reported $302 million in revenue for Q2 2025, with a gross margin of 61% and adjusted EBITDA of $111 million [7][15] - Curaleaf's Q2 2025 net revenue was $314.5 million, an 8% decline from the previous year, with a gross margin of 49% [10][11] - Green Thumb Industries reported Q2 2025 revenue of $293.3 million, a 4.7% increase year-over-year, with a gross margin of 49.9% [14][15] Market Positioning - Trulieve is recognized for its retail penetration and product distribution, supported by a large loyalty program with over 725,000 members [4][7] - Curaleaf's extensive retail and wholesale network positions it well for continued expansion, despite recent revenue challenges [8][11] - Green Thumb's strategy combines brand development with an expanding retail footprint, contributing to steady sales growth [12][14] Investment Considerations - The cannabis sector remains volatile, necessitating careful technical analysis and disciplined risk management for traders [1][2] - Companies with strong fundamentals and expanding footprints are likely to benefit from ongoing industry developments [2][15] - Investors are advised to monitor technical setups while applying risk management strategies to navigate the market effectively [16]

Core Insights - The cannabis sector is experiencing a rally due to potential regulatory changes, with bipartisan support for descheduling cannabis, which could present investment opportunities [4][6][59] - The AdvisorShares Pure US Cannabis ETF (MSOS) is highlighted as a significant investment vehicle, with approximately $840 million in assets under management, providing concentrated exposure to the US cannabis market [6][12] - The quant analysis indicates that MSOS has shown excellent momentum and liquidity, recently shifting from a sell to a buy rating due to positive market sentiment surrounding cannabis legalization [12][16] ETF Analysis - MSOS is characterized as an actively managed ETF, which cannot directly own many US cannabis stocks due to federal regulations, instead utilizing investment swaps to achieve similar financial results [21][22] - The ETF's evaluation metrics include momentum, expenses, risk, and liquidity, with momentum being a strong predictive factor for buy/sell signals [8][10][25] - The quant score for MSOS currently stands at 4.35, with thresholds determining the transition from buy to hold or sell ratings based on various performance metrics [25] Company Insights - Verano Holdings (OTCQX:VRNOF) is identified as a strong buy, with a market cap of approximately $500 million, showing positive momentum and strong valuation metrics despite the overall sector's challenges [27][30] - Vext Science (OTCQX:VEXTF) is another notable company, with a market cap of around $60 million, demonstrating significant profitability and growth metrics, making it an attractive investment option [35][36] - Green Thumb Industries (OTCQX:GTBIF) is recognized for its strong balance sheet but faces challenges in growth metrics, indicating a potential long-term investment rather than an immediate buy [47][50] Market Context - The cannabis industry is still in a nascent stage, with significant regulatory uncertainty impacting growth and profitability across many companies [28][39] - Canadian cannabis companies, such as Tilray (TLRY) and SNDL, are noted for their more mature market position, providing a less risky investment alternative compared to US-based companies [39][42] - The overall sentiment in the cannabis sector is influenced by political developments and potential legislative changes, which could significantly impact investment strategies [59][60]

Core Insights - High Tide's Canna Cabana retail cannabis store has shown consistent growth, reaching 203 locations across Canada by July 2025, with significant expansions in Alberta and Ontario [1][8] - Canna Cabana achieved a 12% market share in the cannabis retail market, with stores generating 2.3 times the revenue of competitors [2][8] - The Canadian legal cannabis market was valued at $3.25 billion in 2024, with a projected CAGR of 12% from 2025 to 2030, driven by federal legalization and increased health awareness [3] Company Performance - High Tide's shares increased by 76.2% over the past year, significantly outperforming the industry growth of 3.3% and the S&P 500's 15.5% [7] - The company reported approximately $6.8 million in retail sales from April 17 to April 20, 2025 [2] Market Dynamics - The Ontario government increased the cannabis retail store cap from 75 to 150 locations, enhancing High Tide's growth potential in the largest cannabis market in Canada [3][8] - Peer companies like Village Farms and Aurora Cannabis are also experiencing significant growth, with Village Farms reporting a 690% increase in international medical export sales and Aurora Cannabis seeing an 85% rise in international medical cannabis sales [4][6] Valuation Metrics - High Tide currently trades at a forward Price-to-Sales (P/S) ratio of 0.55X, compared to the industry average of 5.60X, indicating a discounted valuation [9]

Industry Overview - The U.S. cannabis industry is rapidly expanding, with legal cannabis sales exceeding $29 billion in 2024 and projected to surpass $45 billion by 2030 as legalization spreads [1] - Ancillary companies provide essential technology, data, and cultivation tools to dispensaries and growers, allowing them to operate efficiently without direct plant-touching risks [1] - Recent developments regarding potential federal legalization and banking reform have renewed investor interest in ancillary stocks [1] Company Highlights Leafly Holdings (LFLY) - Leafly is a major cannabis marketplace in the U.S., connecting consumers to legal cannabis products and dispensaries, with over 4,600 retailers using its platform [3][5] - The company reported quarterly revenue of approximately $7.9 million, with a trailing twelve-month revenue near $33.5 million, indicating strong performance despite industry volatility [5] - Management has focused on cost control and sustainable growth, with cash conservation measures providing flexibility in a challenging capital environment [5] WM Technology / Weedmaps (MAPS) - Weedmaps operates as a leading marketplace and software platform for cannabis businesses, listing dispensaries and brands, with over 5,200 paying clients [6][7] - The company reported quarterly revenue of $44.8 million, with adjusted EBITDA increasing to $11.7 million, reflecting improved profitability trends [7] - Weedmaps holds nearly $59 million in cash, providing strategic flexibility, and aims to enhance monetization through upselling software and marketing services [7] GrowGeneration (GRWG) - GrowGeneration focuses on cultivation support, operating hydroponic and gardening superstores without owning dispensaries, with 29 retail locations across 11 states [8][10] - The company achieved second-quarter net sales of $41 million, a 14.7% increase from the previous quarter, with gross margins improving to 28.3% [10] - GrowGeneration holds $48.7 million in cash and has no debt, positioning it well for long-term growth and recovery in the cannabis sector [10] Investment Considerations - Ancillary cannabis stocks like Leafly, Weedmaps, and GrowGeneration are critical to the U.S. cannabis ecosystem, providing necessary technology and supplies [11] - Each company presents unique growth opportunities despite ongoing industry challenges, making them worth monitoring for potential investment [11]